Detalles de la búsqueda
1.
A pilot study utilizing multi-omic molecular profiling to find potential targets and select individualized treatments for patients with previously treated metastatic breast cancer.
Breast Cancer Res Treat
; 147(3): 579-88, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25209003
2.
Phase I Study of Elraglusib (9-ING-41), a Glycogen Synthase Kinase-3ß Inhibitor, as Monotherapy or Combined with Chemotherapy in Patients with Advanced Malignancies.
Clin Cancer Res
; 30(3): 522-531, 2024 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37982822
3.
Malignant glioma subset from actuate 1801: Phase I/II study of 9-ING-41, GSK-3ß inhibitor, monotherapy or combined with chemotherapy for refractory malignancies.
Neurooncol Adv
; 4(1): vdac012, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35402914
Resultados
1 -
3
de 3
1
Próxima >
>>